|
1
|
Savage SA and Mirabello L: Using
epidemiology and genomics to understand osteosarcoma etiology.
Sarcoma. 2011:5481512011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar
|
|
3
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013.PubMed/NCBI
|
|
5
|
Bastid J: EMT in carcinoma progression and
dissemination: facts, unanswered questions, and clinical
considerations. Cancer Metastasis Rev. 31:277–283. 2012. View Article : Google Scholar
|
|
6
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: an emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
May CD, Sphyris N, Evans KW, Werden SJ,
Guo W and Mani SA: Epithelial-mesenchymal transition and cancer
stem cells: a dangerously dynamic duo in breast cancer progression.
Breast Cancer Res. 13:2022011. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Morel AP, Lievre M, Thomas C, Hinkal G,
Ansieau S and Puisieux A: Generation of breast cancer stem cells
through epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar
|
|
9
|
Bacchetti S and Counter C: Telomeres and
telomerase in human cancer (review). Int J Oncol. 7:423–432.
1995.PubMed/NCBI
|
|
10
|
Meyerson M: Role of telomerase in normal
and cancer cells. J Clin Oncol. 18:2626–2634. 2000.PubMed/NCBI
|
|
11
|
Gomez DE, Armando RG, Farina HG, et al:
Telomere structure and telomerase in health and disease (review).
Int J Oncol. 41:1561–1569. 2012.PubMed/NCBI
|
|
12
|
Kim NW, Piatyszek MA, Prowse KR, et al:
Specific association of human telomerase activity with immortal
cells and cancer. Science. 266:2011–2015. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sanders RP, Drissi R, Billups CA, Daw NC,
Valentine MB and Dome JS: Telomerase expression predicts
unfavorable outcome in osteosarcoma. J Clin Oncol. 22:3790–3797.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shay JW and Bacchetti S: A survey of
telomerase activity in human cancer. Eur J Cancer. 33:787–791.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hiyama E, Hiyama K, Yokoyama T and Shay
JW: Immunohistochemical detection of telomerase (hTERT) protein in
human cancer tissues and a subset of cells in normal tissues.
Neoplasia. 3:17–26. 2001. View Article : Google Scholar
|
|
16
|
Liu Z, Li Q, Li K, et al: Telomerase
reverse transcriptase promotes epithelial-mesenchymal transition
and stem cell-like traits in cancer cells. Oncogene. 32:4203–4213.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wick M, Zubov D and Hagen G: Genomic
organization and promoter characterization of the gene encoding the
human telomerase reverse transcriptase (hTERT). Gene. 232:97–106.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takakura M, Kyo S, Kanaya T, et al:
Cloning of human telomerase catalytic subunit (hTERT) gene promoter
and identification of proximal core promoter sequences essential
for transcriptional activation in immortalized and cancer cells.
Cancer Res. 59:551–557. 1999.
|
|
19
|
Cong YS, Wen J and Bacchetti S: The human
telomerase catalytic subunit hTERT: organization of the gene and
characterization of the promoter. Hum Mol Genet. 8:137–142. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Niinaka Y, Harada K, Fujimuro M, et al:
Silencing of autocrine motility factor induces
mesenchymal-to-epithelial transition and suppression of
osteosarcoma pulmonary metastasis. Cancer Res. 70:9483–9493. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Funasaka T, Hu H, Yanagawa T, Hogan V and
Raz A: Down-regulation of phosphoglucose isomerase/autocrine
motility factor results in mesenchymal-to-epithelial transition of
human lung fibrosarcoma cells. Cancer Res. 67:4236–4243. 2007.
View Article : Google Scholar
|
|
22
|
Funasaka T, Hogan V and Raz A:
Phosphoglucose isomerase/autocrine motility factor mediates
epithelial and mesenchymal phenotype conversions in breast cancer.
Cancer Res. 69:5349–5356. 2009. View Article : Google Scholar
|
|
23
|
Kirkpatrick KL, Clark G, Ghilchick M,
Newbold RF and Mokbel K: hTERT mRNA expression correlates with
telomerase activity in human breast cancer. Eur J Surg Oncol.
29:321–326. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saretzki G, Petersen S, Petersen I, Kolble
K and von Zglinicki T: hTERT gene dosage correlates with telomerase
activity in human lung cancer cell lines. Cancer Lett. 176:81–91.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ito H, Kyo S, Kanaya T, Takakura M, Inoue
M and Namiki M: Expression of human telomerase subunits and
correlation with telomerase activity in urothelial cancer. Clin
Cancer Res. 4:1603–1608. 1998.PubMed/NCBI
|
|
26
|
Shigeishi H, Sugiyama M, Tahara H, et al:
Increased telomerase activity and hTERT expression in human
salivary gland carcinomas. Oncol Lett. 2:845–850. 2011.
|
|
27
|
Gibbs CP Jr, Levings PP and Ghivizzani SC:
Evidence for the osteosarcoma stem cell. Curr Orthop Pract.
22:322–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Siclari VA and Qin L: Targeting the
osteosarcoma cancer stem cell. J Orthop Surg Res. 5:782010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marian CO, Cho SK, McEllin BM, et al: The
telomerase antagonist, imetelstat, efficiently targets glioblastoma
tumor-initiating cells leading to decreased proliferation and tumor
growth. Clin Cancer Res. 16:154–163. 2010. View Article : Google Scholar
|
|
30
|
Kirkpatrick KL, Newbold RF and Mokbel K:
The mRNA expression of hTERT in human breast carcinomas correlates
with VEGF expression. J Carcinog. 3:12004. View Article : Google Scholar
|
|
31
|
Park JI, Venteicher AS, Hong JY, et al:
Telomerase modulates Wnt signalling by association with target gene
chromatin. Nature. 460:66–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
